Citadel Advisors’s 10x Genomics TXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$282K Buy
13,300
+2,800
+27% +$56K ﹤0.01% 10600
2025
Q4
$171K Sell
10,500
-33,500
-76% -$506K ﹤0.01% 11177
2025
Q3
$514K Buy
44,000
+700
+2% +$9.13K ﹤0.01% 9067
2025
Q2
$501K Sell
43,300
-6,600
-13% -$60.2K ﹤0.01% 8621
2025
Q1
$436K Buy
49,900
+5,500
+12% +$69.3K ﹤0.01% 8778
2024
Q4
$638K Buy
44,400
+16,200
+57% +$256K ﹤0.01% 8008
2024
Q3
$637K Buy
28,200
+9,700
+52% +$201K ﹤0.01% 7749
2024
Q2
$360K Buy
18,500
+8,600
+87% +$225K ﹤0.01% 8754
2024
Q1
$372K Sell
9,900
-23,800
-71% -$1.05M ﹤0.01% 9005
2023
Q4
$1.89M Sell
33,700
-12,100
-26% -$527K ﹤0.01% 5463
2023
Q3
$1.89M Buy
45,800
+16,200
+55% +$843K ﹤0.01% 5321
2023
Q2
$1.65M Sell
29,600
-41,700
-58% -$2.26M ﹤0.01% 5497
2023
Q1
$3.98M Buy
71,300
+50,400
+241% +$2.35M ﹤0.01% 4171
2022
Q4
$762K Sell
20,900
-3,700
-15% -$121K ﹤0.01% 7364
2022
Q3
$701K Sell
24,600
-38,100
-61% -$1.45M ﹤0.01% 7741
2022
Q2
$2.84M Buy
62,700
+36,900
+143% +$1.91M ﹤0.01% 4857
2022
Q1
$1.96M Buy
25,800
+13,200
+105% +$1.15M ﹤0.01% 6122
2021
Q4
$1.88M Sell
12,600
-91,200
-88% -$14M ﹤0.01% 6404
2021
Q3
$15.1M Buy
103,800
+93,700
+928% +$16.1M ﹤0.01% 2420
2021
Q2
$1.98M Sell
10,100
-2,000
-17% -$362K ﹤0.01% 6644
2021
Q1
$2.19M Sell
12,100
-3,400
-22% -$587K ﹤0.01% 6179
2020
Q4
$2.19M Sell
15,500
-5,400
-26% -$784K ﹤0.01% 5170
2020
Q3
$2.61M Buy
20,900
+7,100
+51% +$745K ﹤0.01% 4232
2020
Q2
$1.23M Buy
13,800
+1,700
+14% +$132K ﹤0.01% 5438
2020
Q1
$754K Buy
12,100
+800
+7% +$62.4K ﹤0.01% 5807
2019
Q4
$862K Buy
+11,300
New +$679K ﹤0.01% 5867

Other funds holding TXG